IPLEX® method and MassARRAY® system for genotyping the allelic variants

PM Parvaneh Mehrbod
SE Sana Eybpoosh
BF Behrokh Farahmand
FF Fatemeh Fotouhi
MA Majid Khanzadeh Alishahi
request Request a Protocol
ask Ask a question
Favorite

The extracted DNA samples were transferred to Inqaba Biotech Co, South Africa, to determine the genotypes of the allelic variants using iPLEX® and MassARRAY® platform (Sequenom MassARRAY® System, San Diego, USA). This SNP genotyping method involves an initial PCR reaction specific to the locus followed by single base extension using mass-modified primers containing terminal deoxyribonucleotides that binds immediately upstream of the polymorphism site. Using Matrix-Assisted Laser Desorption/Ionization-Time Of Flight (MALDI-TOF) Mass Spectrometry (MS), the specific mass of the amplified primer determines the SNP allele. This procedure involves the following steps: Pre-PCR for DNA (5 to 50 ng /µl) and oligonucleotides preparation, PCR for target locus amplification using designed primers, Post-PCR for purification of the reaction with SAP (Shrimp alkaline phosphatase), Single base amplification with iPLEX system, Cleaning products with resin, Deployment of amplified products on SpectroCHIPs, and Products tracking with Mass Spectrometry with appropriate MALDI-TOF matrix [35]. The specifications of the oligos for iPLEX SNP genotyping are shown in Table Table22.

The specifications of the oligos for iPLEX SNP genotyping

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A